Login
From:
Pulse Today
(Uncensored)
subscribe
Semaglutide cuts risk of cardiovascular events by 20%, claims manufacturer - Pulse Today
https://www.pulsetoday.co.uk/news/clinical-areas/cardiovascular/semaglutide-cuts-risk-of-cardiovascular-events-by-20-claims-manufacturer/
links
backlinks
Roast topics
Find topics
Find it!
Diabetes drug semaglutide, marketed as Wegovy, could also reduce risk of cardiovascular events by 20%, its manufacturer has claimed.
